Aquinox Pharmaceuticals Inc (AQXP) - Financial Analysis Review

Summary

Aquinox Pharmaceuticals Inc (Aquinox) is a clinical stage pharmaceutical company that discovers and develops targeted treatments in areas such as inflammation and immuno-oncology. The company provides products such as AQX-1125 and next generation SHIP1 activators; a natural modulator of the PI3K pathway, to reduce inflammation. Aquinox is in clinical trials for the treatment of chronic obstructive pulmonary disease (COPD), bladder pain syndrome (BPS)/ interstitial cystitis (IC), allergic asthma, and atopic dermatitis, others. The company operates with British Columbia Cancer Agency and the University of British Columbia to carry out its research.

GlobalData's Aquinox Pharmaceuticals Inc (AQXP) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Aquinox Pharmaceuticals Inc Key Recent Developments:

Nov 09,2016: Aquinox Pharmaceuticals Announces Third Quarter 2016 Financial Results
Aug 04,2016: Aquinox Pharmaceuticals Announces Second Quarter 2016 Financial Results
Mar 14,2016: Aquinox Pharmaceuticals Announces Year End 2015 Financial Results
Dec 16,2015: Aquinox Selected for Addition to NASDAQ Biotechnology Index
Nov 10,2015: Aquinox Pharmaceuticals Reports Third Quarter 2015 Financial Results


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.